Skip to Main Content

Author Details

David H MacLennan
1963
284
93
PMIDPaper TitleJournal TitlePublished Year
28687594Reduced threshold for store overload-induced Ca release is a common defect of RyR1 mutations associated with malignant hyperthermia and central core disease.Biochemical Journal2017
26040000Metformin increases degradation of phospholamban via autophagy in cardiomyocytes.Proc Natl Acad Sci U S A2015
25619131Muscle spindles exhibit core lesions and extensive degeneration of intrafusal fibers in the Ryr1(I4895T/wt) mouse model of core myopathy.Biochemical and Biophysical Research Communications2015
25614869Exome analysis identifies Brody myopathy in a family diagnosed with malignant hyperthermia susceptibility.Mol Genet Genomic Med2014
25418327Variably protease-sensitive prionopathy, a unique prion variant with inefficient transmission properties.Emerging Infectious Diseases2014
23460944CASQ1 gene is an unlikely candidate for malignant hyperthermia susceptibility in the North American population.Anesthesiology2013
23978697Type 2 ryanodine receptor domain A contains a unique and dynamic α-helix that transitions to a β-strand in a mutant linked with a heritable cardiomyopathy.Journal of Molecular Biology2013
23183335Novel excitation-contraction uncoupled RYR1 mutations in patients with central core disease.Neuromuscular Disorders2013
22203976Type 1 ryanodine receptor knock-in mutation causing central core disease of skeletal muscle also displays a neuronal phenotype.Proceedings of the National Academy of Sciences of the United States of America2012
22913516Structural determination of the phosphorylation domain of the ryanodine receptor.FEBS J2012
21697544Enhanced Ca2+ transport and muscle relaxation in skeletal muscle from sarcolipin-null mice.Am J Physiol Cell Physiol2011
21118704Mechanistic models for muscle diseases and disorders originating in the sarcoplasmic reticulum.2011
21149547Muscle weakness in Ryr1I4895T/WT knock-in mice as a result of reduced ryanodine receptor Ca2+ ion permeation and release from the sarcoplasmic reticulum.Journal of General Physiology2011
21455645Ryanodine receptor type 1 gene mutations found in the Canadian malignant hyperthermia population.Canadian Journal of Anaesthesia2011
21454501Identification of novel ryanodine receptor 1 (RyR1) protein interaction with calcium homeostasis endoplasmic reticulum protein (CHERP).J Biol Chem2011
20937869Constitutively active calcineurin induces cardiac endoplasmic reticulum stress and protects against apoptosis that is mediated by alpha-crystallin-B.Proc Natl Acad Sci U S A2010
19959667Ca2+ dysregulation in Ryr1(I4895T/wt) mice causes congenital myopathy with progressive formation of minicores, cores, and nemaline rods.Proc Natl Acad Sci U S A2009
19139388Alterations of phospholamban function can exhibit cardiotoxic effects independent of excessive sarcoplasmic reticulum Ca2+-ATPase inhibition.Circulation2009
19541610Crystal structure of type I ryanodine receptor amino-terminal beta-trefoil domain reveals a disease-associated mutation "hot spot" loop.Proceedings of the National Academy of Sciences of the United States of America2009
19567749Store overload-induced Ca2+ release as a triggering mechanism for CPVT and MH episodes caused by mutations in RYR and CASQ genes.Journal of Physiology2009
18378906Tbx5-dependent pathway regulating diastolic function in congenital heart disease.Proc Natl Acad Sci U S A2008
18053795Interaction sites among phospholamban, sarcolipin, and the sarco(endo)plasmic reticulum Ca(2+)-ATPase.Biochemical and Biophysical Research Communications2008
18056057Comparative proteomics profiling of a phospholamban mutant mouse model of dilated cardiomyopathy reveals progressive intracellular stress responses.Mol Cell Proteomics2008
17172675Analyzing the cardiac muscle proteome by liquid chromatography-mass spectrometry-based expression proteomics.Methods Mol Biol2007
17084242Cardiovascular proteomics: tools to develop novel biomarkers and potential applications.J Am Coll Cardiol2006
16461894Cardiac-specific overexpression of sarcolipin in phospholamban null mice impairs myocyte function that is restored by phosphorylation.Proc Natl Acad Sci U S A2006
16432188A mutation in the human phospholamban gene, deleting arginine 14, results in lethal, hereditary cardiomyopathy.Proc Natl Acad Sci U S A2006
16595628Cardiac-specific elevations in thyroid hormone enhance contractility and prevent pressure overload-induced cardiac dysfunction.Proc Natl Acad Sci U S A2006
16163667Correlations between genotype and pharmacological, histological, functional, and clinical phenotypes in malignant hyperthermia susceptibility.Human Mutation2005
15824125Proteome dynamics during C2C12 myoblast differentiation.Mol Cell Proteomics2005
15979338Multidimensional protein identification technology (MudPIT): technical overview of a profiling method optimized for the comprehensive proteomic investigation of normal and diseased heart tissue.J Am Soc Mass Spectrom2005
15689621Ca2+ signaling in HEK-293 and skeletal muscle cells expressing recombinant ryanodine receptors harboring malignant hyperthermia and central core disease mutations.Journal of Biological Chemistry2005
15226293Role of the sequence surrounding predicted transmembrane helix M4 in membrane association and function of the Ca(2+) release channel of skeletal muscle sarcoplasmic reticulum (ryanodine receptor isoform 1).Journal of Biological Chemistry2004
15556994Sarcolipin retention in the endoplasmic reticulum depends on its C-terminal RSYQY sequence and its interaction with sarco(endo)plasmic Ca(2+)-ATPases.Proc Natl Acad Sci U S A2004
15371420HSP70 binds to the fast-twitch skeletal muscle sarco(endo)plasmic reticulum Ca2+ -ATPase (SERCA1a) and prevents thermal inactivation.J Biol Chem2004
16118852Interactions of the calcium ATPase with phospholamban and sarcolipin: structure, physiology and pathophysiology.Journal of Muscle Research and Cell Motility2004
14982994Identification of biochemical adaptations in hyper- or hypocontractile hearts from phospholamban mutant mice by expression proteomics.Proc Natl Acad Sci U S A2004
15201433Cardiac-specific overexpression of sarcolipin inhibits sarco(endo)plasmic reticulum Ca2+ ATPase (SERCA2a) activity and impairs cardiac function in mice.Proc Natl Acad Sci U S A2004
15175001Central core disease mutations R4892W, I4897T and G4898E in the ryanodine receptor isoform 1 reduce the Ca2+ sensitivity and amplitude of Ca2+-dependent Ca2+ release.Biochem J2004
15133025Roles of conserved P domain residues and Mg2+ in ATP binding in the ground and Ca2+-activated states of sarcoplasmic reticulum Ca2+-ATPase.Journal of Biological Chemistry2004
14987197Probing nucleotide-binding effects on backbone dynamics and folding of the nucleotide-binding domain of the sarcoplasmic/endoplasmic-reticulum Ca2+-ATPase.Biochemical Journal2004
12637367Chronic SR Ca2+-ATPase inhibition causes adaptive changes in cellular Ca2+ transport.Circulation Research2003
12556521Targeted disruption of the ATP2A1 gene encoding the sarco(endo)plasmic reticulum Ca2+ ATPase isoform 1 (SERCA1) impairs diaphragm function and is lethal in neonatal mice.J Biol Chem2003
12525698Modeling of the inhibitory interaction of phospholamban with the Ca2+ ATPase.Proceedings of the National Academy of Sciences of the United States of America2003
12610310Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban.Science2003
12838339Phospholamban: a crucial regulator of cardiac contractility.Nature Reviews Molecular Cell Biology2003
12883402Detection of a novel ryanodine receptor subtype 1 mutation (R328W) in a malignant hyperthermia family by sequencing of a leukocyte transcript.Anesthesiology2003
12883401Protocol for the sequence analysis of ryanodine receptor subtype 1 gene transcripts from human leukocytes.Anesthesiology2003
12763867The regulation of SERCA-type pumps by phospholamban and sarcolipin.Annals of the New York Academy of Sciences2003
12763781ATP binding residues of sarcoplasmic reticulum Ca2+-ATPase.Annals of the New York Academy of Sciences2003
  • 1 - 50 of 284

Recommended Authors

Collaborators

University of Toronto, University Avenue
Co-authored papers 19
Co-authored papers 13
Co-authored papers 13
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Co-authored papers 11
Boston University School of Medicine, Boston University
Co-authored papers 9
New York University Grossman School of Medicine
Co-authored papers 7
Co-authored papers 5
Brigham and Women's Hospital (Y.K.
Co-authored papers 4
Hospital for Sick Children
Co-authored papers 4
Harvard Medical School
Co-authored papers 4
University of Toronto, College Street
Co-authored papers 4
Co-authored papers 3
Co-authored papers 3
Leiden University Medical Center (LUMC)Leiden
Co-authored papers 2
National and Kapodistrian University of Athens
Co-authored papers 2
The Roslin Institute and R(D)SVS, University of Edinburgh
Co-authored papers 2
Co-authored papers 2
University of Toronto
Co-authored papers 2
University of Cincinnati
Co-authored papers 2
Dana-Farber Cancer Institute
Co-authored papers 1
Center for Genetics, Children's Hospital Oakland Research Institute
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
The Hospital for Sick Children
Co-authored papers 1
University of Toronto
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
The Hospital for Sick Children
Co-authored papers 1
Gladstone Institutes of Cardiovascular Disease, Gladstone Institutes
Co-authored papers 1